Tumor Response and Progression-Free Survival as Potential Surrogate Endpoints for Overall Survival in Extensive-Stage Small Cell Lung Cancer (ES-SCLC): Findings Based on North Central Cancer Treatment Group (NCCTG) Trials
- Citation:
- Cancer vol 117 (6) 1262-1271
- Year:
- 2011
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- U10 CA025224, U10 CA025224-26, CA25, 224
- Corr. Author:
- Authors:
- Nathan R. Foster Yingwei Qi Qian Shi James E. Krook John W. Kugler James R. Jett Julian R. Molina Steven E. Schild Alex A. Adjei Sumithra J. Mandrekar
- Networks:
- Study
- NCCTG-N0424
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- Keywords:
- extensive-stage small cell lung cancer, surrogate endpoints, pooled analysis, progression-free survival, tumor response